Tozaro has developed a new wave of affinity purification ligands to help gene therapy manufacturers produce viral vectors faster, more efficiently, and with higher product quality. Their first product, an RUO lentivirus magnetic bead, is designed for rapid process development and early-stage research, enabling users to generate more insights faster, through high-yield, high-purity viral vector purification at research scale.

Built on its proprietary Smart Polymer™ Platform, the company’s affinity ligands for lentivirus and AAV deliver high functional recovery while removing more than 99% of residual DNA and host cell proteins. Compatible with membranes, monoliths, and other chromatography formats, the technology enables rapid purification workflows, greater manufacturing flexibility, and simplified process development. Following an $8 million fundraise, Tozaro is expanding adoption of its platform through integration with leading chromatography media and advancing toward broader commercial product launches.